Skip to main content
. 2022 Feb;84(1):1–6. doi: 10.18999/nagjms.84.1.1

Table 1.

Baseline characteristics and intraoperative data from each group before and after propensity score-matching

Before matching After matching
Ketamine (+)
n=129
Ketamine (–)
n=121
P-
value
Ketamine (+)
n=89
Ketamine (–)
n=89
P-
value
Age; years 65 [55–72] 67 [55–72] 0.84 65 [55–72] 64 [54–73] 0.91
Sex; Male/female 78/51 77/44 0.70 57/32 50/39 0.36
BMI; kg/m2 22.0 ± 4.3 21.2 ± 3.4 0.12 21.5 ± 3.9 21.5 ± 3.5 1.00
Operation time; min 674 ± 118 648 ± 115 0.09 662 ± 119 652 ± 120 0.56
Anesthesia time; min 775 ± 120 742 ± 120 0.03* 759 ± 118 748 ± 127 0.53
In-Out balance; mL 3002 [2250–3776] 2733 [2192–3800] 0.45 2955 [2067–3748] 2878 [2114–3800] 0.95
Blood transfusion 73 (57%) 81 (67%) 0.12 53 (60%) 55 (62%) 0.88
TIVA with propofol 6 (5%) 4 (3%) 0.75 4 (5%) 3 (3%) 1.00
NSAIDs (flurbiprofen) 28 (22%) 22 (18%) 0.53 15 (17%) 18 (20%) 0.70
Free flap reconstruction 98 (76%) 85 (70%) 0.32 67 (75%) 63 (71%) 0.61
Fentanyl dose; ng/kg/min 23.8 ± 5.6 22.4 ± 6.2 0.07 22.8 ± 5.5 23.3 ± 6.5 0.59

Values are presented as means ± standard deviations, medians [interquartile ranges], or numbers (proportion, %) of patients.

BMI: body mass index

TIVA: total intravenous anesthesia

NSAIDs: nonsteroidal anti-inflammatory drugs